Image: Global mammography market to reach USD 3.4 Billion in 2028 due to increasing prevalence of breast cancer (Photo courtesy of CDC)
The global mammography market is expected to reach USD 3.4 billion in 2028, driven by the increasing prevalence of breast cancer across the globe, rising government fund for ongoing research on breast cancer, and increasing public awareness about cancer. The market growth is being fueled further by increasing number of screening programs and campaigns to create awareness about breast cancer, improving healthcare infrastructure and facilities, and technological advancements in breast imaging techniques.
These are the latest findings of Reports and Data (New York, NY, USA), a provider of market research and consultancy services.
The rising prevalence of breast cancer across the globe is resulting in increasing demand for enhanced breast imaging systems. Factors such as rapid growth of the geriatric population, increasing investments in research & development activities, improving reimbursement schemes, rising increasing healthcare spending, and increasing awareness about early screening and diagnosis of breast cancer are boosting market growth. In addition, increasing demand for advanced breast cancer screening and diagnostic tools in hospitals, ambulatory care, and diagnostic centers, and increasing investments for developing advanced mammograms are also expected to fuel market growth in the coming years. However, high initial investments, unawareness about mammography systems and early breast cancer diagnosis and treatment in remote areas, and side effects of excess radiation exposure are key factors that could hamper the growth of the mammography market.
Based on technology, the breast tomosynthesis market is expected to register the fastest revenue CAGR over the forecast period on the back of increasing demand for technologically advanced breast cancer detecting systems, high patient pool, and continuous technological advancements in breast cancer diagnostic tools. Based on usage, the screening segment is expected to account for a larger revenue share between 2021 and 2028, owing to a large patient pool, rising risks of breast cancer, increasing awareness about screening, and increasing demand for advanced screening mammograms in various medical centers. Among the end use segment, the ambulatory surgical centers segment is expected to register a rapid revenue growth, led by the increasing incidence of breast cancer, rising public awareness about early screening, diagnosis, and treatment, increasing healthcare expenditure and availability of cost effective services.
Geographically, the mammography market in Europe is expected to register a significantly high revenue growth due to rising incidence of breast cancer, rising public awareness about breast cancer risks, and importance of early diagnosis and treatment, the presence of well-developed healthcare infrastructure, availability of advanced mammography systems, and increasing investments in R&D activities. The Asia Pacific mammography market is expected to expand at a rapid pace owing to factors such as increasing prevalence of breast cancer, improving healthcare facilities, rising healthcare spending, and increasing number of awareness programs about breast health and cancer.
Reports and Data